Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma - Wikidata - awgldk - TriplyDB

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

http://www.wikidata.org/entity/Q28281028

about

Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Immunological deregulation in classic hodgkin lymphoma.Prognostic factors in hodgkin lymphoma Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.Decision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment.Prognostic Biomarkers for Hodgkin Lymphoma.Phagocytized neutrophil fragments in the bone marrow: a phenomenon most commonly associated with hodgkin lymphoma.Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.Recent treatment advances in Hodgkin lymphoma: a concise review.Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.Mechanisms underlying the association between obesity and Hodgkin lymphoma.Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells.Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.Basal cell carcinoma arising from xeroderma pigmentosum: a case report and an immunohistochemical study.Evaluation of the inflammatory response in macrophages stimulated with exosomes secreted by Mycobacterium avium-infected macrophages.PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study.Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation.Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.Combination of plasma HA and circulating M2-like monocytes may serve as a diagnostic marker for breast cancer.Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding.Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.Detection of an atypical teratoid rhabdoid brain tumor gene deletion in circulating blood using next-generation sequencing.A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.Increased circulating M2-like monocytes in patients with breast cancer.Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC.Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphoma.Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17

P2860

Q26799114-2F4617EF-248F-453A-B81B-4609931D6718 Q30248284-AB35D1A3-198C-4D09-8521-5191B4B7F7FB Q33778391-CC4DF8A4-749A-44FA-86F8-4D3C5F4BB844 Q33920147-B9917C88-950C-4433-9AF9-EFE6EF7E503C Q34627838-2079006D-26AD-4CB0-882E-62D48F65F6FA Q36706850-4D1A40FA-42AC-40AE-982D-6BECBDF0C0CF Q36825808-808453DB-2475-42E7-8103-6E7EBBAB6745 Q37134780-3DDD3312-1D8F-4C49-A54B-0AB0FF9858C5 Q37417538-644AB663-2407-4F67-B8D8-10507F00F975 Q38337152-BCBBEE29-7732-4B0E-9140-33F7894A5D25 Q38588503-9648F060-1FD4-467B-A285-7A22C6FBE5B0 Q38626833-C5716B72-4ACE-4020-8B20-94FD71D78EBB Q38754419-E26C634F-A21D-4ACD-B359-B4911458BF8F Q38755955-AD9ECFFE-568E-4FAF-8738-233885B3F028 Q38775871-8ABDA2FC-CF23-4359-A4A9-3C81A41628F3 Q38910560-ACF6DDD5-9AF0-437B-84DD-950C7515CAF0 Q39036600-135636F4-B94E-4512-98EB-02517F668090 Q39235262-8591B423-0587-496A-BE71-6BC89745F371 Q39423479-6666A91D-A116-4F78-83A2-17C0C48F9CCB Q39631326-B47E8BF7-643A-454B-96CE-F036A1F889ED Q41345150-2AD4EF16-8EAC-455C-ADF5-0C65E9ADB493 Q41826795-7363AA9D-EA36-4899-BCBA-4D76E40C2899 Q41892187-51DC7A7A-C397-4498-96B4-40134E7D3B82 Q42426888-23E710C8-A4E5-42C1-99D3-44A38BE884B0 Q42553277-6C5CE48E-3D88-4189-BE14-A16AC77E43E5 Q43648582-BFEAD32D-7F82-4D43-B2FE-D6F8C57E6F62 Q47151942-E7E868A7-5F70-42B8-A9BA-175A7C1A6B5D Q47852690-CC206C41-8E47-4ABF-87AF-091B8D46E203 Q48923254-833CA857-929C-4D08-8877-7B1597D32EA9 Q50101286-74341C8C-EF30-4706-B18E-6EB5A34AB1F1 Q50545382-34A86C44-5B68-41B3-B81A-35825303E4CF Q50929848-A0BBF4A4-B713-44A5-B4A7-C124D67D3B1C Q51526266-B928B500-B1B0-41CF-A231-FC8A530118CE Q52990308-D96389E5-E0F2-4499-8063-5120F95958D8 Q58582706-44A27416-1D7B-471E-B459-301A6B570BC6 Q58729611-19E4868F-F62A-49C7-9344-505C458D2DBC

P2860

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

http://www.wikidata.org/entity/Q28281028

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@ast

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@en

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@nl

type

label

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@ast

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@en

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@nl

prefLabel

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@ast

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@en

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@nl

P1433

Q28281028-11645CB0-F111-4B41-8988-E1AA17AF9C48

P1476

Q28281028-D4C4D0AA-7FB0-4102-9E3F-60F35ED63C5B

P2093

Q28281028-0E234E8F-CA56-4511-B758-07B56B0AAC2E

Q28281028-3C2F8A47-4CFD-488C-BA24-59DED5F7272D

Q28281028-40E9EA18-39C1-4DDB-878E-2F672DBD50C3

Q28281028-62C53D34-E5EC-48D0-A1E5-BF1FE57D2590

Q28281028-6A8D461F-FE1E-47FD-A88E-6BF4B476CA13

Q28281028-9D75072F-0D3D-445A-A334-E6D95978249B

Q28281028-AC429017-AA07-4829-957B-5F034F4B4F53

Q28281028-C222D7E3-04B5-4A15-8A99-E7D185A0E9C9

Q28281028-D685D5FB-0DA5-4CDF-9BA2-A820EDDFDA5F

P304

Q28281028-6639A34A-F193-44F7-848E-AA416FB58859

P31

Q28281028-CF397E70-72DD-4090-9D11-F1EF47680380

P3181

Q28281028-9030FCA8-40AD-4F8F-BC6C-9CE4FFD5B2B8

P356

Q28281028-37B1EA00-F8D1-4ED6-A56E-76FCBAC1D2DA

P407

Q28281028-5F6992E7-C053-4DDD-9CAD-C87F218F9B13

P433

Q28281028-72DECCA1-C5F6-43D8-ADCF-317CC82FD8AE

P478

Q28281028-6879BE59-1C2A-4508-9E91-1F618867AEF2

P50

Q28281028-31133F0C-7AD4-4AAB-B0F9-A2E146DA0B30

P577

Q28281028-D4F8F130-28BF-462C-9F8E-5C5ABE587D10

P698

Q28281028-0DB3846F-E0B6-47B2-A3DF-47DBB344630B

P921

Q28281028-DABEFBE6-0722-4390-B4C8-5AD87B47708A

P3181

P356

1078-0432.CCR-12-2693

P1433

Clinical Cancer Research

P1476

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

@en

P2093

Colm Keane

http://www.w3.org/2001/XMLSchema#string

David Gottlieb

http://www.w3.org/2001/XMLSchema#string

David Ritchie

http://www.w3.org/2001/XMLSchema#string

Devinder Gill

http://www.w3.org/2001/XMLSchema#string

Jamie P Nourse

http://www.w3.org/2001/XMLSchema#string

Kimberley Jones

http://www.w3.org/2001/XMLSchema#string

Louise A Seymour

http://www.w3.org/2001/XMLSchema#string

Maher K Gandhi

http://www.w3.org/2001/XMLSchema#string

Pauline Crooks

http://www.w3.org/2001/XMLSchema#string

P304

731-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

488594

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-12-2693

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23224400

http://www.w3.org/2001/XMLSchema#string

P921